Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan
Author:
Affiliation:
1. National Center for Global Health and Medicine Ichikawa Japan
2. Gilead Sciences Inc. Foster City CA USA
3. Gilead Sciences K.K. Chiyoda‐ku Japan
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13395
Reference33 articles.
1. 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
2. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
3. Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan
4. Past, Present, and Future of Viral Hepatitis C in Japan
5. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review;Drug Safety;2024-08-19
2. Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data;Viral Hepatitis Journal;2023-12-26
3. Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study;The Korean Journal of Internal Medicine;2022-11-01
4. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study;BMJ Open;2022-06
5. Ledipasvir/sofosbuvir;Reactions Weekly;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3